ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Alexion Pharmaceuticals Inc

Alexion Pharmaceuticals Inc (ALXN)

182.50
0.00
(0.00%)
終値: 1月30日 6:00AM
182.50
0.00
( 0.00% )
取引時間後: -

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
182.50
買値
183.00
売値
185.00
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
182.50
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

ALXN 最新ニュース

Moderna Set to Join S&P 500

Moderna Set to Join S&P 500 PR Newswire NEW YORK, July 15, 2021 NEW YORK, July 15, 2021 /PRNewswire/ -- Moderna Inc. (NASD:MRNA) will replace Alexion Pharmaceuticals Inc. (NASD:ALXN) in the...

Alexion Announces Positive Topline Results from Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Adults with Generalized My...

– Study met primary endpoint of change from baseline in the Myasthenia Gravis-Activities of Daily Living Profile (MG-ADL) total score at Week 26 – – ULTOMIRIS demonstrated compelling efficacy as...

Honeywell International Inc. to Join the NASDAQ-100 Index Beginning July 21, 2021

NEW YORK, July 14, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Honeywell International Inc. (Nasdaq: HON), will become a component of the NASDAQ-100 Index® (Nasdaq: NDX...

Caelum & Alexion Present Additional Phase 2 Data Reinforcing Safety & Tolerability of CAEL-101 in AL Amyloidosis at the Europ...

- Exploratory biomarker analyses suggest possible cardiac disease improvements and renal response - Caelum Biosciences and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced new Phase 2...

 Alexion Announces FDA Approval of ULTOMIRIS® (ravulizumab-cwvz) for Children & Adolescents with Paroxysmal Nocturnal Hemog...

 – With this approval, ULTOMIRIS is the first and only medicine approved in the U.S. to treat children and adolescents with PNH – – Approval based on interim results from Phase 3 study showing...

Caelum and Alexion Announce Upcoming CAEL-101 Data Presentations at the European Hematology Association Congress 2021

- Accepted abstracts include new Phase 2 safety and tolerability data for CAEL-101 in AL amyloidosis - - Phase 3 studies of CAEL-101 in AL amyloidosis are underway - Caelum Biosciences and...

Alexion Announces Upcoming Data Presentations at the 26th European Hematology Association Virtual Congress

– Long-term data evaluate the effectiveness of ULTOMIRIS® (ravulizumab-cwvz) in reducing the risk of thrombosis in PNH, the primary cause of organ damage and premature death in untreated patients...

Alexion Shareholders Approve Acquisition by AstraZeneca

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that its shareholders have voted to adopt and approve the previously announced agreement to be acquired by AstraZeneca at a special...

Alexion Reports First Quarter 2021 Results

1Q21 total revenues of $1,636.5 million, a 13% increase over 1Q20 1Q21 GAAP diluted EPS of $2.86; non-GAAP diluted EPS of $3.52 Completed enrollment in Phase 3 studies of ULTOMIRIS®...

UPDATED Alexion to Report First Quarter 2021 Results on Friday, April 30, 2021

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the first quarter ended March 31, 2021 before the US financial markets open on...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ALXN - Frequently Asked Questions (FAQ)

What is the current Alexion Pharmaceuticals share price?
The current share price of Alexion Pharmaceuticals is US$ 182.50
What is the 1 year trading range for Alexion Pharmaceuticals share price?
Alexion Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
PCSAProcessa Pharmaceuticals Inc
US$ 0.8626
(45.64%)
479.02k
CARMCarisma Therapeutics Inc
US$ 0.6959
(37.91%)
3.08M
GMHSGamehaus Holdings Inc
US$ 2.50
(30.21%)
48.12k
OSTOstin Technology Group Company Ltd
US$ 3.53
(21.55%)
729.46k
EDSAEdesa Biotech Inc
US$ 2.15
(17.51%)
2.5k
MXLMaxLinear Inc
US$ 18.00
(-17.36%)
57.09k
RFACRF Acquisition Corporation
US$ 5.95
(-14.51%)
353
IKTInhibikase Therapeutics Inc
US$ 2.4201
(-14.18%)
73.39k
DSYBig Tree Cloud Holdings Limited
US$ 1.75
(-10.26%)
1.03k
IFBDInfobird Company Ltd
US$ 1.95
(-10.14%)
160.78k
NVDANVIDIA Corporation
US$ 125.00
(0.98%)
24.18M
VCSHVanguard Short Term Corporate Bond
US$ 78.43
(0.01%)
9.57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 24.8403
(0.81%)
7.28M
TSLATesla Inc
US$ 389.0253
(0.26%)
5.59M
MGOLMGO Global Inc
US$ 0.112199
(10.11%)
4.39M

ALXN Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock